article thumbnail

Process improvements and in-person monitoring help U.S. pharmaceutical company achieve on time for Phase III clinical trials

Syner-G

pharmaceutical company to oversee a 6 month, DS manufacturing as Person-In- Plant (PIP) and assist with preparation of associated submission documents related to Phase III clinical trial batches. Download The Case Study The post Process improvements and in-person monitoring help U.S.

article thumbnail

Developing a first-in-class small molecule drug for inflammatory disease

European Pharmaceutical Review

To ensure an efficient process, MyMD works closely with the contract manufacturing organisation (CMO) focusing on automation and process improvement. All pharmaceutical companies want to save on the cost of production, but not at the expense of quality. This allows us to stay on top of quality control.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to conduct product quality review in pharmaceutical

GMPSOP

Trending will help identify product and process improvements. Subscribe Prev PREVIOUS POST Kazi Hasan Kazi is a seasoned pharmaceutical industry professional with over 20 years of experience specializing in production operations, quality management, and process validation.

article thumbnail

Patient Centricity for Pharma Marketing – Quiz

PharmaState Academy

a) Maximizing Profits through maximum patient's care b) Putting Patients First c) Regulatory Compliance and patient outcome d) Internal Processes improvement to improve patient's health outcomes 5 / 20 How can patient-centric marketing contribute to better healthcare outcomes?

Dosage 59